
EU Annex 11 Explained: Ensuring Data Integrity in Pharmaceuticals
Pharmaceutical firms must prioritize data integrity and robust procedures to meet FDA and EU regulatory expectations. Understanding their detailed guidelines is vital for compliance and data quality. Successfully navigating these regulations requires mastering FDA and EU requirements, including best practices for data management. Companies should dedicate resources to implementing data integrity principles from both FDA and EU guidance.